Montelukast

Preview FDA label, Rising Pharma Holdings, Inc., oral, effective 2026-05-29. Full label on DailyMed

Quoted from the FDA label. Product labels differ by manufacturer and change over time; confirm against the label for the product you are using. Not yet reviewed by a ClinDose pharmacist.

Dosing in kidney impairment

Renal Impairment No dosage adjustment is recommended in patients with renal insufficiency [see Clinical Pharmacology ].

Dosing in liver impairment

Hepatic Impairment No dosage adjustment is recommended in patients with mild-to-moderate hepatic insufficiency [see Clinical Pharmacology ].